Cargando…

Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease

BACKGROUND: Myocardial infarct heterogeneity indices including peri-infarct gray zone are predictors for spontaneous ventricular arrhythmias events after ICD implantation in patients with ischemic heart disease. In this study we hypothesize that the extent of peri-infarct gray zone and papillary mus...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuesong, Connelly, Kim A, Zeidan-Shwiri, Tawfiq, Lu, Yingli, Paul, Gideon, Roifman, Idan, Zia, Mohammad I, Graham, John J, Dick, Alexander J, Crystal, Eugene, Wright, Graham A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702486/
https://www.ncbi.nlm.nih.gov/pubmed/23803259
http://dx.doi.org/10.1186/1532-429X-15-57
_version_ 1782275817717366784
author Yang, Yuesong
Connelly, Kim A
Zeidan-Shwiri, Tawfiq
Lu, Yingli
Paul, Gideon
Roifman, Idan
Zia, Mohammad I
Graham, John J
Dick, Alexander J
Crystal, Eugene
Wright, Graham A
author_facet Yang, Yuesong
Connelly, Kim A
Zeidan-Shwiri, Tawfiq
Lu, Yingli
Paul, Gideon
Roifman, Idan
Zia, Mohammad I
Graham, John J
Dick, Alexander J
Crystal, Eugene
Wright, Graham A
author_sort Yang, Yuesong
collection PubMed
description BACKGROUND: Myocardial infarct heterogeneity indices including peri-infarct gray zone are predictors for spontaneous ventricular arrhythmias events after ICD implantation in patients with ischemic heart disease. In this study we hypothesize that the extent of peri-infarct gray zone and papillary muscle infarct scores determined by a new multi-contrast late enhancement (MCLE) method may predict appropriate ICD therapy in patients with ischemic heart disease. METHODS: The cardiovascular magnetic resonance (CMR) protocol included LV functional parameter assessment and late gadolinium enhancement (LGE) CMR using the conventional method and MCLE post-contrast. The proportion of peri-infarct gray zone, core infarct, total infarct relative to LV myocardium mass, papillary muscle infarct scores, and LV functional parameters were statistically compared between groups with and without appropriate ICD therapy during follow-up. RESULTS: Twenty-five patients with prior myocardial infarct for planned ICD implantation (age 64±10 yrs, 88% men, average LVEF 26.2±10.4%) were enrolled. All patients completed the CMR protocol and 6–46 months follow-up at the ICD clinic. Twelve patients had at least one appropriate ICD therapy for ventricular arrhythmias at follow-up. Only the proportion of gray zone measured with MCLE and papillary muscle infarct scores demonstrated a statistically significant difference (P < 0.05) between patients with and without appropriate ICD therapy for ventricular arrhythmias; other CMR derived parameters such as LVEF, core infarct and total infarct did not show a statistically significant difference between these two groups. CONCLUSIONS: Peri-infarct gray zone measurement using MCLE, compared to using conventional LGE-CMR, might be more sensitive in predicting appropriate ICD therapy for ventricular arrhythmia events. Papillary muscle infarct scores might have a specific role for predicting appropriate ICD therapy although the exact mechanism needs further investigation.
format Online
Article
Text
id pubmed-3702486
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37024862013-07-06 Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease Yang, Yuesong Connelly, Kim A Zeidan-Shwiri, Tawfiq Lu, Yingli Paul, Gideon Roifman, Idan Zia, Mohammad I Graham, John J Dick, Alexander J Crystal, Eugene Wright, Graham A J Cardiovasc Magn Reson Research BACKGROUND: Myocardial infarct heterogeneity indices including peri-infarct gray zone are predictors for spontaneous ventricular arrhythmias events after ICD implantation in patients with ischemic heart disease. In this study we hypothesize that the extent of peri-infarct gray zone and papillary muscle infarct scores determined by a new multi-contrast late enhancement (MCLE) method may predict appropriate ICD therapy in patients with ischemic heart disease. METHODS: The cardiovascular magnetic resonance (CMR) protocol included LV functional parameter assessment and late gadolinium enhancement (LGE) CMR using the conventional method and MCLE post-contrast. The proportion of peri-infarct gray zone, core infarct, total infarct relative to LV myocardium mass, papillary muscle infarct scores, and LV functional parameters were statistically compared between groups with and without appropriate ICD therapy during follow-up. RESULTS: Twenty-five patients with prior myocardial infarct for planned ICD implantation (age 64±10 yrs, 88% men, average LVEF 26.2±10.4%) were enrolled. All patients completed the CMR protocol and 6–46 months follow-up at the ICD clinic. Twelve patients had at least one appropriate ICD therapy for ventricular arrhythmias at follow-up. Only the proportion of gray zone measured with MCLE and papillary muscle infarct scores demonstrated a statistically significant difference (P < 0.05) between patients with and without appropriate ICD therapy for ventricular arrhythmias; other CMR derived parameters such as LVEF, core infarct and total infarct did not show a statistically significant difference between these two groups. CONCLUSIONS: Peri-infarct gray zone measurement using MCLE, compared to using conventional LGE-CMR, might be more sensitive in predicting appropriate ICD therapy for ventricular arrhythmia events. Papillary muscle infarct scores might have a specific role for predicting appropriate ICD therapy although the exact mechanism needs further investigation. BioMed Central 2013-06-26 /pmc/articles/PMC3702486/ /pubmed/23803259 http://dx.doi.org/10.1186/1532-429X-15-57 Text en Copyright © 2013 Yang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Yang, Yuesong
Connelly, Kim A
Zeidan-Shwiri, Tawfiq
Lu, Yingli
Paul, Gideon
Roifman, Idan
Zia, Mohammad I
Graham, John J
Dick, Alexander J
Crystal, Eugene
Wright, Graham A
Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease
title Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease
title_full Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease
title_fullStr Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease
title_full_unstemmed Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease
title_short Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease
title_sort multi-contrast late enhancement cmr determined gray zone and papillary muscle involvement predict appropriate icd therapy in patients with ischemic heart disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702486/
https://www.ncbi.nlm.nih.gov/pubmed/23803259
http://dx.doi.org/10.1186/1532-429X-15-57
work_keys_str_mv AT yangyuesong multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT connellykima multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT zeidanshwiritawfiq multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT luyingli multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT paulgideon multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT roifmanidan multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT ziamohammadi multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT grahamjohnj multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT dickalexanderj multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT crystaleugene multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease
AT wrightgrahama multicontrastlateenhancementcmrdeterminedgrayzoneandpapillarymuscleinvolvementpredictappropriateicdtherapyinpatientswithischemicheartdisease